MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases
Biomolecules · 28.07.2023 · 13 (8) · 1185
DOI: 10.3390/biom13081185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 28.07.2023. Verfasst von Chao Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Guizhou University, Guiyang 550025, China. Hauptthemen laut MEDLINE: MicroRNAs, Encephalitis, Inflammatory Bowel Diseases, RNA, Small Untranslated. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Special field project of Guizhou Provincial Education Department, Guizhou Province science and technology cooperation plan.
Abstract (Originalsprache)
MicroRNAs (miRNAs) are a class of small noncoding RNA that can regulate physiological and pathological processes through post-transcriptional regulatory gene expression. As an important member of the miRNAs family, microRNA-7 (miR-7) was first discovered in 2001 to play an important regulatory role in tissue and organ development. Studies have shown that miR-7 participates in various tissue and organ development processes, tumorigenesis, aging, and other processes by regulating different target molecules. Notably, a series of recent studies have determined that miR-7 plays a key regulatory role in the occurrence of inflammation and related diseases. In particular, miR-7 can affect the immune response of the body by influencing T cell activation, macrophage function, dendritic cell (DC) maturation, inflammatory body activation, and other mechanisms, which has important potential application value in the intervention of related diseases. This article reviews the current regulatory role of miR-7 in inflammation and related diseases, including viral infection, autoimmune hepatitis, inflammatory bowel disease, and encephalitis. It expounds on the molecular mechanism by which miR-7 regulates the occurrence of inflammatory diseases. Finally, the existing problems and future development directions of miR-7-based intervention on inflammation and related diseases are discussed to provide new references and help strengthen the understanding of the pathogenesis of inflammation and related diseases, as well as the development of new strategies for clinical intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Guizhou University, Guiyang 550025, China.
- Department of Immunology, Zunyi Medical University, Zunyi 563000, China.
- Specifc Key Laboratory of Gene Detection and Treatment of Guizhou Province, Zunyi 563000, China.
- Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University, Zunyi 563000, China.
Förderung
- National Natural Science Foundation of China
- Special field project of Guizhou Provincial Education Department
- Guizhou Province science and technology cooperation plan
- The collaborative Innovation Center of Chinese Ministry of Education
- Project of the Department of Science and Technology of Zunyi
Zitieren
APA
Chen, C., Guo, M., Zhao, X., Zhao, J., Chen, L., He, Z., Xu, L., & Zha, Y. (2023). MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases. Biomolecules, 13(8), 1185. https://doi.org/10.3390/biom13081185
Vancouver
Chen C, Guo M, Zhao X, Zhao J, Chen L, He Z, et al. MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases. Biomolecules. 2023;13(8):1185. doi:10.3390/biom13081185
BibTeX
@article{Chen2023,
author = {Chen, Chao and Guo, Mengmeng and Zhao, Xu and Zhao, Juanjuan and Chen, Longqing and He, Zhixu and Xu, Lin and Zha, Yan},
title = {MicroRNA-7: A New Intervention Target for Inflammation and Related Diseases},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {8},
pages = {1185},
doi = {10.3390/biom13081185}
}
EUVIMED